City

Idaho Falls (1)

Laredo (1)

Overall Status

Recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

National Cancer Institute (NCI) (1)

Taproot Health (1)

Collaborator

Intervention

biomarker testing (l) (1)

imc-a12 (1)

patient reported outcomes (p) (1)

systemic treatment (t) (1)

temsirolimus (1)

Study Documents

Intervention Type

drug (2)

diagnostic test (1)

other (1)

Funder Type

Industry (1)

NIH (1)

Study Type

Interventional (1)

Observational [Patient Registry] (1)

brain stem neoplasms

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

Recruiting

Adenocarcinoma
+75 more

Biomarker Testing (L)
+2 more

Idaho Falls, Idaho
+1 more

Oct 18, 2022

Brain Stem Tumors, Glioma, Pinealoma Trial (IMC-A12, Temsirolimus)

Withdrawn

Brain Stem Neoplasms
+2 more

(no location specified)

Jun 30, 2017